Observe Medical Asa (OBSRV) - Total Liabilities

Latest as of December 2025: Nkr71.21 Million NOK ≈ $7.49 Million USD

Based on the latest financial reports, Observe Medical Asa (OBSRV) has total liabilities worth Nkr71.21 Million NOK (≈ $7.49 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore how fast is Observe Medical Asa growing its equity to track the company's year-over-year net asset growth rate.

Observe Medical Asa - Total Liabilities Trend (2016–2025)

This chart illustrates how Observe Medical Asa's total liabilities have evolved over time, based on quarterly financial data.

Observe Medical Asa Competitors by Total Liabilities

The table below lists competitors of Observe Medical Asa ranked by their total liabilities.

Company Country Total Liabilities
Korea Plasma Technology U Co.Ltd
KQ:054410
Korea ₩39.75 Billion
Logisys Inc
KQ:067730
Korea ₩9.08 Billion
Les Hôtels de Paris SA
PA:HDP
France €236.82 Million
ASTORY Co.Ltd
KQ:241840
Korea ₩10.09 Billion
Capital Engineering Network Public Company Limited
BK:CEN
Thailand ฿447.12 Million
Crown Lifters Limited
NSE:CROWN
India Rs1.19 Billion
Antilles Gold Ltd
AU:AAU
Australia AU$1.01 Million
Wooree E&L Co. Ltd
KQ:153490
Korea ₩30.59 Billion

Liability Composition Analysis (2016–2025)

This chart breaks down Observe Medical Asa's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see OBSRV market cap overview.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 0.48 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio 0.26 Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 2.38 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.70 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Observe Medical Asa's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Observe Medical Asa (2016–2025)

The table below shows the annual total liabilities of Observe Medical Asa from 2016 to 2025.

Year Total Liabilities Change
2025-12-31 Nkr71.21 Million
≈ $7.49 Million
-42.71%
2024-12-31 Nkr124.30 Million
≈ $13.08 Million
-6.36%
2023-12-31 Nkr132.74 Million
≈ $13.97 Million
+71.27%
2022-12-31 Nkr77.51 Million
≈ $8.16 Million
-9.73%
2021-12-31 Nkr85.86 Million
≈ $9.04 Million
+27.42%
2020-12-31 Nkr67.39 Million
≈ $7.09 Million
+65.20%
2019-12-31 Nkr40.79 Million
≈ $4.29 Million
-2.90%
2018-12-31 Nkr42.01 Million
≈ $4.42 Million
-20.20%
2017-12-31 Nkr52.64 Million
≈ $5.54 Million
-3.13%
2016-12-31 Nkr54.34 Million
≈ $5.72 Million
--

About Observe Medical Asa

OL:OBSRV Norway Medical Devices
Market Cap
$13.95 Million
Nkr132.61 Million NOK
Market Cap Rank
#26175 Global
#238 in Norway
Share Price
Nkr0.97
Change (1 day)
-2.60%
52-Week Range
Nkr0.56 - Nkr1.25
All Time High
Nkr34.00
About

Observe Medical ASA develops and commercialize medical technology products for patients, healthcare professionals, and hospitals in Europe, Asia, and the Americas. The company offers UnoMeter portfolio comprising Unometer, Safeti Plus, Unometer 500, and UnoMeter AbdoPressure products used for manual urine output measurement and for measuring intra-abdominal pressure. It also provides Sippi, a dig… Read more